Rainfall Health vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $15M Series A (Feb 2026). Built specifically for CMS TEAM model launching January 2026 — mandatory episodic payment reform for 5 major surgical procedures. Up to $100M revenue impact per health system.
About
Rainfall Health is an AI platform built specifically for the CMS Transforming Episode Accountability Model (TEAM), which took effect January 1, 2026 — mandatory episodic payment reform requiring participating hospitals to manage the total cost and quality of care for 90 days following five major surgical procedures: lower extremity joint replacement, surgical hip fracture, spinal fusion, coronary artery bypass graft, and major bowel procedures.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.